NTBL Notable Labs: Company Short-Term Debts

The price chart for Notable Labs, Ltd. (NTBL) illustrates the price action of an asset whose revenue is based on precision therapy selection via drug testing on a patient's live cells. The AI-driven PPND automated system independently analyzes blood tests to accelerate drug screening, with the metric standing at 0.00. High business resilience is ensured by prognostic patents and the ownership of rare databases.

NTBL Notable Labs Ltd Company Short-Term Loans and Borrowings (02/21/2024 - 11/02/2024)

NTBL (Notable Labs Corp): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Notable Labs|NTBL - Consensus Target
- company stock capitalization data:
Market Capitalization Notable Labs, Ltd.|NTBL - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Notable Labs|NTBL - Accounting Value of Company|Market Cap to Net Assets Ratio notablelabs.com|NTBL - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Notable Labs, Ltd.|NTBL - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Notable Labs, Ltd.|NTBL - Company Aggregate Debts|Debt to Book Capitalization Ratio Notable Labs, Ltd.|NTBL - Company Long-Term Loans and Borrowings|Company Short-Term Debts Notable Labs|Quick Liquidity notablelabs.com
- earnings and multiples data:
NTBL - Company Profit
Analysis of all company metrics:NTBL - Notable Labs

The slow implementation of the Notable Labs, Ltd. (NTBL) platform in clinics and uncertainty regarding insurance reimbursements create liquidity risks, directly impacting the volume of short-term borrowings. An analysis of the company's current liabilities allows for the differentiation of speculative growth from a genuine recovery in solvency, where a stabilizing debt trajectory confirms a reduction in capital risks, while an excess of debt signals a crisis in operational efficiency.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|tuhurabio.com - Company Short-Term Indebtedness|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Short-Term Debt|WHWK: Company Current Liabilities|TScan Therapeutics - Amount of Current Liabilities|CSBR: Company Short-Term Debts|XBiotech (XBIT) - Company Short-Term Debts|CVM (CEL-SCI Corp.) - Company Short-Term Debts|Company Short-Term Debt OSTX|Company Short-Term Debt Radiopharm Theranostics (RADX)|Company Short-Term Debt ARTV (artivabio.com)|Company Short-Term Debts ANL (Adlai Nortye)|verupharma.com (VERU) - Short-Term Debt|TPST: Company Current Liabilities|Company Short-Term Loans and Borrowings XLO (Xilio Therapeutics, Inc.)|renovarobio.com (RENB) - Company Short-Term Debt|MURA (Mural Oncology) - Company Short-Term Debt|KAPA (Kairos Pharma Limited) - Company Short-Term Debts|Company Short-Term Debts OnKure|Company Short-Term Debts GDTC|Company Short-Term Debt CRIS (curis.com)|Company Short-Term Debt Apollomics APLM|Short-Term Debt Volume Tharimmune Corporation (THAR)|ADVB: Company Current Liabilities|Company Short-Term Loans and Borrowings GNPX (genprex.com)|calidibio.com (CLDI) - Company Short-Term Debt|SBFM (sunshinebiopharma.com) - Company Short-Term Debt|Company Current Liabilities XBIO|SLRX (Salarius Pharma) - Amount of Current Liabilities|Company Short-Term Debts PPBT|aoncology.com - Company Short-Term Indebtedness|BeiGene - Company Current Liabilities|Short-Term Debt Volume Checkpoint Therapeutics Inc. (CKPT)|ELEV - Company Short-Term Debt|ICAD (iCAD, Inc.) - Company Short-Term Indebtedness|IKNA (ikenaoncology.com) - Company Current Liabilities|VIRX: Amount of Current Liabilities|MOR (MorphoSys) - Company Short-Term Debts|Company Short-Term Debt NAYA|Company Short-Term Debt Ascentage Pharma Group Ltd (AAPGV)